A July RNCOS report highlighting the burgeoning market of cardiac medical devices in the U.S. projects the market will reach a compound annual growth rate (CAGR) of an estimated 9 percent by 2015. 

The report, "U.S. Cardiac Device Market Analysis," emphasizes the regulatory scenario for medical devices in the U.S. and highlights key laws that govern the sector.

The report also covers an in-depth analysis of the competitive landscape with regard to cardiac medical devices in the U.S., according to report officials, and broadly elaborates on the major players in terms of their business description, financial performance, strengths and weaknesses and key activities. 

[See also: Medical device industry feeling ill over SCOTUS healthcare ruling.]

The increasing prevalence of cardiovascular diseases has remained a serious concern for U.S. healthcare officials, as mortalities continue to rise altogether contributing to a heightened economic burden. 

Heart disease remains the leading cause of death for both women and men, and in 2008, more than 616,000 people died of heart disease, according to officials at the Centers for Disease Control (CDC).  

An aging population and the demand for innovative treatment options are consistently boosting the cardiac medical device market, making it one of the most prominent healthcare segments in the country. RNCOS officials have estimated that the country has approximately 80 million persons living with cardiovascular diseases, and the total direct cost associated with the disease is an estimated $314 billion. 

To gauge the disease burden, RNCOS's new research offers comprehensive insight into the prevalence of cardiovascular diseases in the U.S., mortality by disease areas, number of procedures performed and their mean cost.

Overall, the report is an outcome of an extensive research and analysis of the U.S. cardiac medical device market that seeks to provide clients with an optimum source of knowledge and statistics on the concerned industry.